Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Liu, Changchun

University Of Connecticut Sch Of Med/Dnt
United States

Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care 3U01CA269147-04S1 Christos Patriotis, Ph.D., M.Sc.
Liu, Yang

University Of Illinois At Urbana-Champaign
United States

Imaging nanoscale chromatin folding in early carcinogenesis 5R01CA254112-07 Matthew Young, Ph.D.
Livneh, Zvi

Weizmann Institute Of Science
United States

Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort 5U01CA279001-03 Claire Zhu, Ph.D.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer 5R01CA254036-05 Matthew Young, Ph.D.
Lokshin, Anna E

University Of Pittsburgh At Pittsburgh
United States

Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms 5R01CA247220-05 Christos Patriotis, Ph.D., M.Sc.
Lowry, Kathryn Paige

University Of Washington
United States

Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations 5R37CA292399-02 Claire Zhu, Ph.D.
Lu, Junxuan

Pennsylvania State Univ Hershey Med Ctr
United States

Early clinial trials for Angelica herbal supplements for prostate cancer interception 4R01CA260901-04 Gabriela Riscuta, M.D., CNS
Lubman, David M.

University Of Michigan At Ann Arbor
United States

Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach 5R01CA160254-14 Matthew Young, Ph.D.
Lyden, David Charles

Weill Medical Coll Of Cornell Univ
United States

Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection 5R01CA218513-08 Matthew Young, Ph.D.
Maclean, Paul S.

University Of Colorado Denver
United States

Novel dietary interventions for reducing obesity-associated breast cancer 5R01CA258766-04 Young Kim, Ph.D.
Madeleine, Margaret M

Fred Hutchinson Cancer Center
United States

Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center 3U54CA242977-07S4 Maria Silvina Frech, Ph.D., M.S.
Mahan, Kristin Eckel

University Of Texas Hlth Sci Ctr Houston
United States

Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain 1R21CA292148-01 John Clifford, Ph.D.
Mahan, Kristin Eckel

University Of Texas Hlth Sci Ctr Houston
United States

Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain 1R21CA292148-01 John Clifford, Ph.D.
Maitra, Anirban

New York University School Of Medicine
United States

Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D.
Maitra, Anirban

New York University School Of Medicine
United States

Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials